Assenagon Asset Management’s Chegg CHGG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-272,504
Closed -$439K – 1191
2024
Q4
$439K Sell
272,504
-26,251
-9% -$48.4K ﹤0.01% 1217
2024
Q3
$529K Buy
298,755
+41,174
+16% +$101K ﹤0.01% 1236
2024
Q2
$814K Hold
257,581
– – ﹤0.01% 1146
2024
Q1
$1.95M Buy
+257,581
New +$2.36M ﹤0.01% 905
2023
Q4
– Sell
-306,122
Closed -$2.73M – 1413
2023
Q3
$2.73M Sell
306,122
-1,028,249
-77% -$10M 0.01% 745
2023
Q2
$11.8M Buy
1,334,371
+300,174
+29% +$3.64M 0.04% 327
2023
Q1
$16.9M Buy
1,034,197
+271,105
+36% +$5.07M 0.06% 275
2022
Q4
$19.3M Sell
763,092
-219,614
-22% -$5.58M 0.07% 249
2022
Q3
$20.7M Buy
982,706
+551,029
+128% +$11.4M 0.08% 240
2022
Q2
$8.11M Buy
431,677
+116,176
+37% +$2.66M 0.03% 427
2022
Q1
$11.4M Sell
315,501
-512,027
-62% -$15.4M 0.03% 337
2021
Q4
$25.4M Buy
+827,528
New +$33.6M 0.07% 185
2021
Q2
– Sell
-53,617
Closed -$4.59M – 1227
2021
Q1
$4.59M Buy
+53,617
New +$5.11M 0.02% 532
2020
Q4
– Sell
-28,008
Closed -$2M – 1045
2020
Q3
$2M Buy
+28,008
New +$2.06M 0.01% 588

Other funds holding CHGG

Assenagon Asset Management's CHGG Position: Q1 2025 in Review

Assenagon Asset Management sold out of Chegg (CHGG) in Q1 2025, closing a stake of 272,504 shares — an estimated $439K sold.

Assenagon Asset Management first reported a position in CHGG in Q3 2020 and held it in 14 quarters. The position peaked at $25.4M in Q4 2021. 155 funds tracked by Wall St. Rank hold CHGG as of Q1 2025.

  • Assenagon Asset Management reported no remaining Chegg position as of Q1 2025 after selling out during the quarter.
  • Assenagon Asset Management sold 272,504 Chegg shares in Q1 2025, an estimated $439K.
  • Assenagon Asset Management first reported a position in Chegg in Q3 2020 and held it in 14 quarters.
  • Assenagon Asset Management's Chegg position peaked at $25.4M in Q4 2021.
  • 155 funds tracked by Wall St. Rank held Chegg as of Q1 2025.

Based on Assenagon Asset Management's 13F filing for Q1 2025, filed 15 Apr 2025.